K Number
K043022
Manufacturer
Date Cleared
2005-03-15

(132 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Stryker Flexible CystoNephroscope is indicated for use during minimally invasive urological procedures through natural body offices or through perculaneous access, and is intended for but not limited to, examining the uning tract and the interior of the kidney, and, using additional accessories, performing diagnostic and therapeutic procedures.

Device Description

The Stryker Flexible CystoNephroscope is a modification of the currently marketed Stryker Flexible Ureteroscope, with changes to labeling, performance, materials, and intended use. The Stryker Flexible CystoNephroscope is a flexible endoscope with active deflection capability.

AI/ML Overview

This 510(k) summary describes a traditional device submission, not an AI/ML powered medical device. Therefore, the requested information regarding acceptance criteria, study details, and AI/ML specific metrics (like sample sizes for test/training sets, ground truth establishment for AI, MRMC, or standalone performance) is not applicable or present in the provided text.

The document primarily focuses on establishing substantial equivalence to a predicate device based on commonalities in materials, performance, and intended use, as per FDA's requirements for traditional medical devices.

Here's an overview of the device and the basis for its clearance as presented in the document:

Device Information:

  • Proprietary Name: Stryker Flexible CystoNephroscope
  • Common and Usual Name: Endoscope, Cystoscope, Nephroscope
  • Classification Name: Endoscope, Cystoscope, Nephroscope
  • Intended Use: Indicated for use during minimally invasive urological procedures through natural body orifices or percutaneous access. Intended for, but not limited to, examining the urinary tract and the interior of the kidney, and, using additional accessories, diagnostic and therapeutic procedures.
  • Predicate Device: ACMI ACN-2 11001 DD Nephro-Fiberscope (K970427)

Basis for Clearance (Substantial Equivalence):

The Stryker Flexible CystoNephroscope is deemed substantially equivalent to the predicate device in terms of safety and effectiveness. The submission states that it is a modification of a currently marketed Stryker Flexible Ureteroscope, with changes to labeling, performance, materials, and intended use, including the addition of active deflection capability.

The submission also notes: "There are no significant technological or performance differences between the Stryker Flexible CystoNephroscope and the identified predicate devices, nor are there any new questions raised regarding safety or effectiveness that would prevent a finding of substantial equivalence to the identified predicate devices."

The device conforms to voluntary safety standards for endoscopic equipment (ISO 10993 Biological Evaluation of Medical Devices).

Regarding the requested information, which is primarily relevant for AI/ML device studies:

  1. Table of acceptance criteria and reported device performance: Not provided for this type of device submission. Acceptance criteria for traditional medical devices like endoscopes relate to their physical and functional specifications (e.g., deflection angles, illumination, material biocompatibility), and these are typically verified through design verification and validation activities, but not usually presented as a table of "performance" metrics in a 510(k) summary in the same way an AI device's clinical performance would be. The clearance is based on substantial equivalence, implying it meets similar performance standards to the predicate.
  2. Sample size used for the test set and data provenance: Not applicable. There is no "test set" in the context of an AI/ML algorithm. This is a physical medical device.
  3. Number of experts used to establish ground truth and qualifications: Not applicable. Ground truth for an AI algorithm is irrelevant here.
  4. Adjudication method: Not applicable.
  5. Multi-reader multi-case (MRMC) comparative effectiveness study: Not applicable. This is not an AI-assisted diagnostic device.
  6. Standalone performance study: Not applicable, as "standalone" performance refers to an AI algorithm's performance without human intervention.
  7. Type of ground truth used: Not applicable.
  8. Sample size for the training set: Not applicable.
  9. How ground truth for the training set was established: Not applicable.

In summary, the provided text concerns a traditional medical device (an endoscope) and its 510(k) clearance based on substantial equivalence to a predicate device. The detailed questions about AI/ML specific study design, performance metrics, and data handling are not relevant to this type of submission.

{0}------------------------------------------------

510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

K0430yy

Device Name

Proprietary Name:Stryker Flexible CystoNephroscope
Common and Usual Name:Endoscope, Cystoscope, Nephroscope
Classification Name:Endoscope, Cystoscope, Nephroscope

This 510(k) summary of safety and effectiveness is being submitted in accordance with requirements of the SMDA 1990.

The Stryker Flexible CystoNephroscope is substantially equivalent in terms of safety and The Stryker Flexible CystoNephroscope is Substantially Equivalin in Childer Collection Corporation of Corporation of Storz
effectiveness to the currently marketed ACMI ACN-2 11001 DD Nephro-Fiberscope (K970427).

The Stryker Flexible CystoNephroscope is a modification of the currently marketed Stryker The Stryker Flexible Cystolephroscope is a mounce, materials, and intended use. The Stryker
Flexible Ureteroscope, with changes to labeling, performance, mad intended use. Flexible Ureteroscope, with changes to abeling, peromance, ma interess and and of the country of the country of the more in interest of the first Plexible CyStoricphroooops of active deflection capability.

The Stryker Flexible CystoNephroscope is indicated for use during minimally invasive urological The Stryker Flexible Cystonephilosope is through perculaneous access, and is intended for but not
procedures through natural body offices or through perculaneous accessories, procedures through natural body offices of the intent of the kidney, and, using additional accessories,
limited to, examining the uning tract and the intenseduces illulled to, examining the and therapeutic procedures.

The Stryker Flexible CystoNephroscope conforms to the following voluntary safety of Endossanio The Stryker Flexible CystonesticsCope Connemis to the Stocking Comments for the Safety of Endoscopic Equipment, ISO 10993 Biological Evaluation of Medical Devices.

There are no significant technological or performance differences between the Stryter Flexible There are no significant technological of penomance there any new questions raised
CystoNephroscope and the identified predicale devices , nor are there any new substantially CystoNephroscope and the Identified predicate devices, nor and any any any and equivalent to the identified predicate devices.

Contact:

11/1/04
Date:

Christopher L. Cook

Stryker Endoscopy 5900 Optical Court San Jose, CA 95138 Phone: 408-754-2288 408-754-2521 Fax: Email: chris.cook@stryker.com

{1}------------------------------------------------

Image /page/1/Picture/2 description: The image shows a logo for the Department of Human Services. The logo features a stylized eagle with three lines representing its wings. The text "Department of Human Services" is arranged in a circular fashion around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 1 5 2005

Mr. Christopher L. Cook Regulatory Supervisor Stryker Endoscopy 5900 Optical Court SAN JOSE CA 95138

Re: K043022

Trade/Device Name: Stryker Flexible CystoNephroscope Regulation Number: 21 CFR §876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: 78 FAJ and FGA Dated: February 16, 2005 Received: February 17, 2005

Dear Mr. Cook:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{2}------------------------------------------------

This letter will allow you to begin marketing your device as described in your Section 510(k) I ms letter with anow you to ocgin maxing of substantial equivalence of your device to a legally premarket notification: "The PDA mianing of bassanian for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for your de roo of the following numbers, based on the regulation number at the top of this letter:

21 CFR 876.xxxx(Gastroenterology/Renal/Urology)240-276-0115
21 CFR 884.xxxx(Obstetrics/Gynecology)240-276-0115
21 CFR 892.xxxx(Radiology)240-276-0120
Other240-276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification the Also, please note the regulation entitled, formation on your responsibilities under the Act from the 807.77). " Ou may obtain other general and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Device Name: Stryker Fiexible CystoNephroscope

1 : 420 %

Indications for Use:

The Stryker Flexible CystoNephroscope is indicated for use during minimally invasive undigital The Stryker Flexible Cystonephosope is number on through percularies and is intended for procedures accessed through the united on the interior of the kidney, and, using additional
but not limited to, examining the unities and the interprogrammand but not limited to, examining the ennaly and therapeutic procedures.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IE NEEDED) TE DELOW THOLE. Of CDRH, Office of Device Evaluation (ODE)

Kaila Lyons

(Division Sign-Off) Division of Reproductive, Abdominal and Badiological Devices 510(k; Number ________________________________________________________________________________________________________________________________________________________________

Prescription Use
(Per 21 CFR 801.109)

OR

Over-The-Counter-Use_

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.